CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 404 enrolled
Drug / intervention
5% Minoxidil Topical Foam +1 moredrug
Likely dose
5% Minoxidil Topical Foam 1 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01226459
NCT01226459Phase 3Completed

A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia)

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.·interventional·Posted Oct 22, 2010·Updated Jun 10, 2014

In Brief

A Phase 3 clinical trial evaluating 5% Minoxidil Topical Foam and Vehicle Topical Foam for Androgenetic Alopecia. Completed, enrolled 404 participants across 17 sites in 4 countries.

Detailed Summary

This is a six month clinical trial to evaluate the effectiveness and safety in women with Female Pattern Hair Loss (FPHL), comparing a 5% minoxidil topical foam (MTF) formulation applied once a day versus a topical foam vehicle (placebo) formulation applied once a day.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Germany, United Kingdom, United States

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 22, 2010
Enrollment StartSep 1, 2010
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.7 years ago

Interventions

5% Minoxidil Topical Foamdrug

Dosage Form: 5% Minoxidil Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks

Vehicle Topical Foamdrug

Dosage Form: Vehicle Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks